Capital Bank & Trust’s Idexx Laboratories IDXX Stock Holding History

Capital Bank & Trust’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-714	Closed	-$349K	–	274
2021 Q1	$349K	Sell	714 -2	-0.3%	-$1K	﹤0.01%	289
2020 Q4	$358K	Buy	716 +2	+0.3%	+$895	﹤0.01%	281
2020 Q3	$281K	Hold	714	–	–	﹤0.01%	266
2020 Q2	$236K	Hold	714	–	–	﹤0.01%	273
2020 Q1	$173K	Hold	714	–	–	﹤0.01%	292
2019 Q4	$186K	Hold	714	–	–	﹤0.01%	306
2019 Q3	$194K	Hold	714	–	–	﹤0.01%	293
2019 Q2	$197K	Buy	714 +575	+414%	+$142K	﹤0.01%	294
2019 Q1	$31K	Hold	139	–	–	﹤0.01%	437
2018 Q4	$26K	Buy	139 +114	+456%	+$23.4K	﹤0.01%	479
2018 Q3	$6K	Hold	25	–	–	﹤0.01%	703
2018 Q2	$5K	Buy	+25	New	+$5.15K	﹤0.01%	588

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital Bank & Trust's IDXX Position: Q2 2021 in Review

Capital Bank & Trust sold out of Idexx Laboratories (IDXX) in Q2 2021, closing a stake of 714 shares — an estimated $349K sold.

Capital Bank & Trust first reported a position in IDXX in Q2 2018 and held it in 12 quarters. The position peaked at $358K in Q4 2020. 1,034 funds tracked by Wall St. Rank hold IDXX as of Q2 2021.

Capital Bank & Trust reported no remaining Idexx Laboratories position as of Q2 2021 after selling out during the quarter.
Capital Bank & Trust sold 714 Idexx Laboratories shares in Q2 2021, an estimated $349K.
Capital Bank & Trust first reported a position in Idexx Laboratories in Q2 2018 and held it in 12 quarters.
Capital Bank & Trust's Idexx Laboratories position peaked at $358K in Q4 2020.
1,034 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2021.

Based on Capital Bank & Trust's 13F filing for Q2 2021, filed 16 Aug 2021.